A dosimetric analysis of modern consolidative mediastinal radiation for Hodgkin’s lymphoma estimates a much smaller than historically-cited mean lifetime attributable risk of secondary malignancy by age 70 of thyroid (0.063%), lung (5.34%), and breast (2.92%) cancers. | Milgrom, ASCO 2025
